menu
    • menu

    Company profile for Verastem Oncology

    NEW Drugs in Dev: 8
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    When it comes to combatting cancer, we realize there are no “one size fits all” treatment approaches. We understand that every cancer lives in an intricate and complex microenvironment, creating significant unmet needs which must be addressed. It’s why we remain open to new ideas and selectively pursue science with the potential to make a significant impact for physicians, patients and their caregivers. We are focusing o...
    When it comes to combatting cancer, we realize there are no “one size fits all” treatment approaches. We understand that every cancer lives in an intricate and complex microenvironment, creating significant unmet needs which must be addressed. It’s why we remain open to new ideas and selectively pursue science with the potential to make a significant impact for physicians, patients and their caregivers. We are focusing on a portfolio of small molecule drugs inhibiting critical signaling pathways in cancer, including the phosphoinositide 3-kinase (PI3K) and focal adhesion kinase (FAK) pathways.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Verastem OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    117 Kendrick Street, Suite 500, Needham, Massachusetts 02494
    Telephone
    Telephone
    781-465-7936
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.verastem.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/verastemoncology/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/verastemoncolog?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Verastem Oncology Announces Inducement Grants Under Nasdaq Rules
    Verastem Oncology Announces Inducement Grants Under Nasdaq Rules

    12 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260112749150/en/Verastem-Oncology-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    12 Jan 2026
    Share Share
    Verastem Updates RAMP 203 Trial for KRAS G12C+ NSCLC
    Verastem Updates RAMP 203 Trial for KRAS G12C+ NSCLC

    29 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251229302295/en/Verastem-Oncology-Provides-Update-on-RAMP-203-Phase-12-Clinical-Trial-for-Advanced-KRAS-G12C-Mutant-Non-Small-Cell-Lung-Cancer

    BUSINESSWIRE
    29 Dec 2025
    Share Share
    Verastem Oncology Unveils Plan To Speed Up Growth Phase
    Verastem Oncology Unveils Plan To Speed Up Growth Phase

    15 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215015726/en/Verastem-Oncology-Announces-Strategic-Transition-Plan-to-Accelerate-Next-Phase-of-Growth

    BUSINESSWIRE
    15 Dec 2025
    Share Share
    Verastem Oncology To Present At Evercore Healthcare Conference
    Verastem Oncology To Present At Evercore Healthcare Conference

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251125239573/en/Verastem-Oncology-to-Present-at-the-8th-Annual-Evercore-Healthcare-Conference

    BUSINESSWIRE
    25 Nov 2025
    Share Share
    Verastem Oncology Prices $90M Public Stock Offering & Warrants
    Verastem Oncology Prices $90M Public Stock Offering & Warrants

    14 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113480267/en/Verastem-Oncology-Announces-Pricing-of-%2490-Million-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants

    BUSINESSWIRE
    14 Nov 2025
    Share Share
    Verastem Oncology Announces Proposed Offering of Common Stock
    Verastem Oncology Announces Proposed Offering of Common Stock

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113430863/en/Verastem-Oncology-Announces-Proposed-Public-Offering-of-Common-Stock

    BUSINESSWIRE
    13 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search